Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 11 (RPL12P11)

Target
RPL12P11
Molecular classification
Other (Processed pseudogene)
01

Overview

Ribosomal protein L12 pseudogene 11 (RPL12P11, also known as dJ661I20.1) is a human processed pseudogene related to the ribosomal protein L12 gene. Processed pseudogenes are non-functional sequences derived from functional genes, typically by reverse transcription of mRNA and subsequent genomic integration. RPL12P11 does not encode a functional protein and is not transcribed into functional RNA with biological activity. Unlike true ribosomal proteins, which are essential for protein synthesis, pseudogenes like RPL12P11 do not participate in ribosomal assembly, translational regulation, or cellular processes. They are accordingly absent from lists of drug targets and do not play a recognized role in human disease or therapy[4][8].\n\nIf you require details for the canonical functional form (RPL12, ribosomal protein L12), please clarify; RPL12 itself is a component of the large ribosomal subunit but even RPL12 is generally not considered a conventional drug target, except potentially in specialized research regarding ribosome-targeting agents[5][6].

Other names
RPL12L2RPL12_22_1703dJ661I20.1
02

Mechanism of action

None; no drugs target RPL12P11[4][5].

03

Biological functions

None established; as a pseudogene, it does not perform canonical ribosomal or cellular functions.
04

Disease associations

None established; pseudogenes such as RPL12P11 are generally not implicated in disease unless they exert regulatory effects, which is not described for this gene[4][8].
05

Safety considerations

None described; as it is not a target nor involved in disease or therapy[4][5].
06

Interacting drugs

None known; pseudogenes are not therapeutic drug targets[4][5].
07

Biomarkers

None; pseudogenes, including RPL12P11, are not recognized biomarkers[4][5][8].

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 11 (RPL12P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 11 (RPL12P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call